Our Publications

Aggamin is dedicated to advancing scientific knowledge through groundbreaking research and clinical studies. Our focus is on developing therapies for vascular diseases, particularly preeclampsia, and we are committed to sharing our findings with the global medical community.
  • Research Studies

    In-depth studies on vascular diseases and preeclampsia.

  • Clinical Data

    Findings from clinical trials and new therapies.

  • Expert Insights

    Articles on treatment advancements and healthcare innovations.

Administration of recombinant human placental growth factor decreases blood pressure in obese hypertensive pregnant rats.

https://pubmed.ncbi.nlm.nih.gov/32618892/

doi: 10.1097/HJH.0000000000002528

PMID: 32618892

The Aggamin Team